“Safety Profile of 5% Albumin Versus Fresh Frozen Plasma in Therapeutic Plasma Exchange for Guillain-Barré Syndrome”, Planet (Barisal), vol. 9, no. 2, pp. 9–13, Mar. 2026, doi: 10.5281/zenodo.19497028.